Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773)
China
· Delayed Price · Currency is CNY 19.47
-0.10 (-0.51%)
Nov 15, 2024, 2:58 PM CST
Chengdu Kanghong Pharmaceutical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 4,369 | 3,957 | 3,388 | 3,605 | 3,294 | 3,256 | Upgrade
|
| Other Revenue | 0.63 | 0.63 | 0.64 | 0.19 | 1.27 | 0.94 | Upgrade
|
| Revenue | 4,370 | 3,957 | 3,389 | 3,605 | 3,295 | 3,257 | Upgrade
|
| Revenue Growth (YoY) | 16.34% | 16.77% | -6.00% | 9.40% | 1.17% | 11.65% | Upgrade
|
| Cost of Revenue | 457.72 | 438.84 | 391.66 | 355.66 | 330.22 | 264.52 | Upgrade
|
| Gross Profit | 3,912 | 3,519 | 2,997 | 3,250 | 2,965 | 2,993 | Upgrade
|
| Selling, General & Admin | 2,089 | 1,943 | 1,710 | 1,786 | 1,892 | 1,971 | Upgrade
|
| Research & Development | 505.49 | 421.68 | 374 | 1,008 | 1,676 | 286.94 | Upgrade
|
| Other Operating Expenses | 65.61 | 52.75 | 48.47 | 51.08 | 45.92 | 41.46 | Upgrade
|
| Operating Expenses | 2,661 | 2,418 | 2,133 | 2,843 | 3,613 | 2,302 | Upgrade
|
| Operating Income | 1,251 | 1,101 | 864.46 | 407 | -647.52 | 690.7 | Upgrade
|
| Interest Expense | - | - | - | - | -0.5 | - | Upgrade
|
| Interest & Investment Income | 102.91 | 97.53 | 83.14 | 61.55 | 59.97 | 56.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.16 | 0.16 | 0.34 | 0.12 | 2.24 | -1.43 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.29 | -1.39 | -0.65 | -0.94 | -0.58 | 0.97 | Upgrade
|
| EBT Excluding Unusual Items | 1,355 | 1,197 | 947.29 | 467.73 | -586.4 | 746.25 | Upgrade
|
| Impairment of Goodwill | - | - | - | -214.84 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -2 | -0.83 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.08 | 0.01 | - | - | - | - | Upgrade
|
| Asset Writedown | -1.6 | -0.73 | -0.24 | -0.67 | -2.4 | -2.79 | Upgrade
|
| Other Unusual Items | 38.26 | 38.26 | 83.25 | 141.19 | 69.28 | 91.72 | Upgrade
|
| Pretax Income | 1,390 | 1,234 | 1,030 | 393.42 | -519.51 | 835.18 | Upgrade
|
| Income Tax Expense | 210.08 | 202.79 | 164.49 | -27.66 | -249.66 | 116.99 | Upgrade
|
| Earnings From Continuing Operations | 1,180 | 1,031 | 865.81 | 421.08 | -269.85 | 718.19 | Upgrade
|
| Minority Interest in Earnings | 13.31 | 13.64 | 30.86 | 0 | - | - | Upgrade
|
| Net Income | 1,193 | 1,045 | 896.67 | 421.08 | -269.85 | 718.19 | Upgrade
|
| Net Income to Common | 1,193 | 1,045 | 896.67 | 421.08 | -269.85 | 718.19 | Upgrade
|
| Net Income Growth | 23.34% | 16.52% | 112.94% | - | - | 3.35% | Upgrade
|
| Shares Outstanding (Basic) | 918 | 916 | 915 | 915 | 870 | 873 | Upgrade
|
| Shares Outstanding (Diluted) | 918 | 916 | 915 | 915 | 870 | 873 | Upgrade
|
| Shares Change (YoY) | 0.56% | 0.16% | -0.05% | 5.16% | -0.34% | 0.55% | Upgrade
|
| EPS (Basic) | 1.30 | 1.14 | 0.98 | 0.46 | -0.31 | 0.82 | Upgrade
|
| EPS (Diluted) | 1.30 | 1.14 | 0.98 | 0.46 | -0.31 | 0.82 | Upgrade
|
| EPS Growth | 22.65% | 16.33% | 113.04% | - | - | 2.77% | Upgrade
|
| Free Cash Flow | 1,314 | 1,080 | 569.95 | -75.3 | -348.53 | -150.73 | Upgrade
|
| Free Cash Flow Per Share | 1.43 | 1.18 | 0.62 | -0.08 | -0.40 | -0.17 | Upgrade
|
| Dividend Per Share | 0.380 | 0.380 | 0.150 | 0.100 | 0.100 | 0.280 | Upgrade
|
| Dividend Growth | 153.33% | 153.33% | 50.00% | 0% | -64.29% | 29.99% | Upgrade
|
| Gross Margin | 89.53% | 88.91% | 88.44% | 90.14% | 89.98% | 91.88% | Upgrade
|
| Operating Margin | 28.62% | 27.82% | 25.51% | 11.29% | -19.65% | 21.20% | Upgrade
|
| Profit Margin | 27.30% | 26.40% | 26.46% | 11.68% | -8.19% | 22.05% | Upgrade
|
| Free Cash Flow Margin | 30.07% | 27.28% | 16.82% | -2.09% | -10.58% | -4.63% | Upgrade
|
| EBITDA | 1,520 | 1,322 | 1,021 | 554.33 | -529.02 | 783.73 | Upgrade
|
| EBITDA Margin | 34.79% | 33.40% | 30.11% | 15.38% | -16.05% | 24.06% | Upgrade
|
| D&A For EBITDA | 269.65 | 221 | 156.12 | 147.33 | 118.5 | 93.03 | Upgrade
|
| EBIT | 1,251 | 1,101 | 864.46 | 407 | -647.52 | 690.7 | Upgrade
|
| EBIT Margin | 28.62% | 27.82% | 25.51% | 11.29% | -19.65% | 21.20% | Upgrade
|
| Effective Tax Rate | 15.11% | 16.43% | 15.96% | - | - | 14.01% | Upgrade
|
| Revenue as Reported | 4,370 | 3,957 | 3,389 | 3,605 | 3,295 | 3,257 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 45.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.